DYFSF yields 2222.22% · PFE yields 6.13%● Live data
📍 DYFSF pulled ahead of the other in Year 1
Combined, DYFSF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of DYFSF + PFE for your $10,000?
dynaCERT Inc. engages in the design, engineering, manufacture, testing, and distribution of transportable hydrogen generator aftermarket products in North America and internationally. Its patented and patent-pending retrofit product provides performance enhancements by injecting hydrogen and oxygen into the air intake manifold resulting in fuel efficiency and reduced carbon emissions. The company offers HydraGen technology that produces hydrogen and oxygen on demand for the aftermarket trucking industry. Its products have applications in various market segments comprising trucks, reefer trailers, buses, heavy construction, mining equipment, electrical power generators, marine, and locomotive. The company was formerly known as Dynamic Fuel Systems, Inc. and changed its name to DynaCERT Inc. in January 2013. DynaCERT Inc. was founded in 2004 and is headquartered in Toronto, Canada.
Full DYFSF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.